The EOLO (End-of-Life Ovarian Cancer) Study: Approach to Ovarian Cancer Patients at the End of Life.

CONCLUSIONS: End-of-life chemotherapy for OC patients is a thorny problem. More studies and a multidisciplinary approach are needed to better treat these patients.
PMID: 31437848 [PubMed - as supplied by publisher]

Source: Oncology - August 21, 2019 Category: Cancer & Oncology Authors: Palaia I, Tomao F, Santangelo G, Di Pinto A, Sassu CM, Perniola G, Musella A, Di Donato V, Giancotti A, Benedetti Panici P Tags: Oncology Source Type: research